PEAR THERAPEUTICS INC's ticker is and the CUSIP is 704723105. A total of 61 filers reported holding PEAR THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $14,278,092 | -42.2% | 12,100,078 | 0.0% | 1.66% | -8.6% |
| Q3 2022 | $24,684,000 | +32.5% | 12,100,078 | 0.0% | 1.82% | +105.9% |
| Q2 2022 | $18,634,000 | -69.5% | 12,100,078 | 0.0% | 0.88% | -54.0% |
| Q1 2022 | $61,105,000 | -18.5% | 12,100,078 | 0.0% | 1.92% | +28.7% |
| Q4 2021 | $75,020,000 | – | 12,100,078 | – | 1.49% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Roble, Belko & Company, Inc | 4,502 | $0 | 0.00% |